VICP OTC
Vicapsys Life Sciences, Inc.
1W: -17.2%
1M: -35.0%
3M: -55.5%
YTD: -56.7%
1Y: -63.3%
3Y: +160.0%
5Y: +73.3%
$0.65
+0.14 (+27.45%)
Weekly Expected Move ±47.6%
$0
$0
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
4 relationships4
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2023-06-02
Earliest Filing
2023-06-30
Latest Filing
licensee: 2
partner: 1
investor: 1
Counterparties (Filed by VICP)
4 relationshipsCompanies named in VICP's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| VICAPSYS LIFE SCIENCES, INC. | VICP | partner | Company issuing the promissory note | 2023-06-30 | View |
| AJB CAPITAL INVESTMENTS, LLC | — | investor | Buyer purchasing the promissory note | 2023-06-30 | View |
| The General Hospital Corporation | — | licensee | Licensor of patent rights in the exclusive patent license agreement | 2023-06-02 | View |
| Vicapsys, Inc | VICP | licensee | Licensee amending the agreement to add new patent rights and pay license fees | 2023-06-02 | View |
Recent 8-K Filings (8)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2023-12-27 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme | Agreement | View |
| 2023-06-30 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2023-06-02 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2023-05-18 | Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits | View | |
| 2023-05-17 | Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits | View | |
| 2023-01-12 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2022-09-28 | Departure/Election of Directors; Appointment of Officers | View | |
| 2022-04-12 | Departure/Election of Directors; Appointment of Officers; Other Events; Financial Statements and Exh | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR